Details for Patent: 3,957,965

Summary for Patent: 3,957,965

Patent landscape, scope, and claims:

Title:	Sodium chromoglycate inhalation medicament
Abstract:	Dosage units comprise a capsule containing a mixture of a solid, finely divided medicament having an effective particle size in the range 0.01 to 10 microns, and a solid, pharmaceutically acceptable, water-soluble carrier having an effective particle size in the range 30 to 80 microns. The compositions are suitable for use in inhalation therapy. The compositions are administered by dispersing the composition into an air stream by subjecting a dosage unit capsule to simultaneous rotation and vibration.
Inventor(s):	Hartley; Philip Saxton (Kegworth, EN), Gunning; Stephen Raymond (East Leake, near Loughborough, EN)
Assignee:	Fisons Limited (London, EN)
Application Number:	05/401,251
Patent Claim Types: see list of patent claims	Composition; Dosage form; Use;

Drugs Protected by US Patent 3,957,965

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 3,957,965

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	36270/67	Aug 8, 1967

International Family Members for US Patent 3,957,965

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Belgium	718846
Canada	946280
Germany	1792207